HULL ANDREW
SEC insider (Form 3/4/5 filer). CIK 0001818252. Director at InMed Pharmaceuticals Inc. (INM). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2025. Located in VANCOUVER, A1.
Companies HULL ANDREW has filed insider reports for
- InMed Pharmaceuticals Inc. (INM): Director
HULL ANDREW
CIK: 0001818252
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
InMed Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 19, 2025INM
InMed Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (Right to Buy)
1.8K shares- - Dec 15, 2025INM
InMed Pharmaceuticals Inc.
Expiration (Short)DirectEmployee Stock Option (Expiration)
14 shares- - Jan 11, 2025INM
InMed Pharmaceuticals Inc.
Expiration (Short)DirectEmployee Stock Option (Expiration)
2 shares- - Dec 20, 2024INM
InMed Pharmaceuticals Inc.
AwardDirectEmployee Stock Option (Right to Buy)
550 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 19, 2025 | INM InMed Pharmaceuticals Inc. | Award Employee Stock Option (Right to Buy) | 1,750 | - | - | Direct |
| Dec 15, 2025 | INM InMed Pharmaceuticals Inc. | Expiration (Short) Employee Stock Option (Expiration) | 14 | - | - | Direct |
| Jan 11, 2025 | INM InMed Pharmaceuticals Inc. | Expiration (Short) Employee Stock Option (Expiration) | 2 | - | - | Direct |
| Dec 20, 2024 | INM InMed Pharmaceuticals Inc. | Award Employee Stock Option (Right to Buy) | 550 | - | - | Direct |
1-4 of 4 transactions